Results 101 to 110 of about 24,931 (209)

The Role of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma With Renal Impairment: A Systematic Review

open access: yesAmerican Journal of Hematology, Volume 101, Issue 7, Page 1484-1493, July 2026.
ABSTRACT Renal impairment (RI), defined as estimated glomerular filtration rate less than 60 mL/min with or without the need for dialysis, is a frequent and severe complication in patients with relapsed/refractory multiple myeloma (RRMM), as it can affect patient prognosis, drug metabolism and treatment options.
Ioannis Ntanasis‐Stathopoulos   +7 more
wiley   +1 more source

Peritoneal Dialysis [PDF]

open access: yesInternational Journal of Nephrology, 2011
Hulya Taskapan   +3 more
openaire   +3 more sources

The efficiency of fractionated parenteral iron treatment in CAPD patients

open access: yes, 1997
17th Annual Conference on Peritoneal Dialysis -- FEB 16-18, 1997 -- DENVER, COSome chronic renal failure patients respond poorly to recombinant human erythropoietin (rHuEPO).
Cirit, M   +8 more
core  

Semaglutide 2.4 mg Cardiometabolic Long‐Term Effects in Patients With Obesity or Overweight in a Real‐World Setting: A Retrospective Cohort Study in the United States (SMILE)

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6121-6130, July 2026.
ABSTRACT Aims To evaluate the real‐world associations between semaglutide 2.4 mg and cardiometabolic comorbidities, biomarkers and cardiovascular risk among adults with overweight or obesity. Methods This retrospective cohort study used US claims data and laboratory measurements from the Komodo Research Database (2016–2024). Adults with obesity or with
Aleksandrina Ruseva   +11 more
wiley   +1 more source

Vascular calcification in peritoneal dialysis patients

open access: yes, 2008
Vascular calcification ( VC) is being recognized as a common complication at all stages of chronic kidney disease, particularly in patients on dialysis.
Ammirati, Adriano Luiz [UNIFESP]   +2 more
core  

The Relationship Between Sublingual Microcirculatory Structure and Frailty in Renal Transplant Candidates: Exploring Tortuosity & Endothelial Glycocalyx Biomarkers

open access: yesMicrocirculation, Volume 33, Issue 5, July 2026.
ABSTRACT Objective This study investigated the relationship between sublingual microcirculatory tortuosity, frailty index scores, and endothelial glycocalyx blood biomarkers in individuals with chronic kidney disease (CKD). Methods Sublingual microcirculatory videos were analyzed using a 0–4 tortuosity scoring scale. Plasma concentrations of syndecan‐1
Ryan A. P. Homes   +6 more
wiley   +1 more source

Effect of peritoneal dialysis and a single hemodialysis on erythrocyte membrane ATPase activity of uremic subjects

open access: yes, 1985
In this study erythrocytic ATPase activities were studied in 21 patients before and after six hours of hemodialysis. In another group of 20 patients ATPase activities were also studied before and after 48-72 hours of peritoneal dialysis.
Hakan O., Emel A., Ali G., Tevfik A.
core  

Intraoperative Collection of Ascitic Fluid With Intra‐ or Postoperative Reinfusion in Ovarian Cancer: Safety and Feasibility of a Roller Pumping Method

open access: yesTherapeutic Apheresis and Dialysis, Volume 30, Issue 3, Page 371-376, June 2026.
ABSTRACT Introduction Patients with ovarian cancer often present with massive ascites, leading to significant protein loss during surgical procedures. Although cell‐free concentrated ascites reinfusion therapy (CART) is used in palliative settings to mitigate protein loss, its application in intraoperative settings remains unexplored.
Yutaka Yoneoka   +7 more
wiley   +1 more source

Optimal use of peritoneal dialysis in patients with diabetes

open access: yes, 2018
The survival of patients with end-stage renal disease (ESRD) resulting from diabetes continues to improve, but the survival rate among diabetic ESRD patients remains the lowest among all primary diagnoses probably because of the higher prevalence of ...
하헌주
core  

Home - About - Disclaimer - Privacy